about
Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.Bridging the gap between evidence and policy for infectious diseases: How models can aid public health decision-makingHow can mathematical models advance tuberculosis control in high HIV prevalence settings?Tuberculosis: From an incurable scourge to a curable disease - journey over a millenniumMolecular profiling of Mycobacterium tuberculosis identifies tuberculosinyl nucleoside products of the virulence-associated enzyme Rv3378cPhylogenetic analysis of vitamin B12-related metabolism in Mycobacterium tuberculosis.Antibodies and tuberculosisControlling the seedbeds of tuberculosis: diagnosis and treatment of tuberculosis infectionThe ongoing challenge of latent tuberculosisAfter 2015: infectious diseases in a new era of health and development.Using Data from Macaques To Predict Gamma Interferon Responses after Mycobacterium bovis BCG Vaccination in Humans: a Proof-of-Concept Study of Immunostimulation/Immunodynamic Modeling Methods.Safety and immunogenicity of an inactivated whole cell tuberculosis vaccine booster in adults primed with BCG: A randomized, controlled trial of DAR-901.Comparison of trends in tuberculosis incidence among adults living with HIV and adults without HIV--Kenya, 1998-2012Limited activity of clofazimine as a single drug in a mouse model of tuberculosis exhibiting caseous necrotic granulomasDiabetes and immunity to tuberculosis.Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countriesHow much is tuberculosis screening worth? Estimating the value of active case finding for tuberculosis in South Africa, China, and India.Role of casual contacts in the recent transmission of tuberculosis in settings with high disease burden.Results of tuberculosis contact investigation in congregate settings in Korea, 2013.The role of B cells and humoral immunity in Mycobacterium tuberculosis infectionGlobal epidemiology of tuberculosis.Effect of isoniazid on antigen-specific interferon-γ secretion in latent tuberculosis.Neither primary nor memory immunity to Mycobacterium tuberculosis infection is compromised in mice with chronic enteric helminth infectionQualification of a whole blood intracellular cytokine staining assay to measure mycobacteria-specific CD4 and CD8 T cell immunity by flow cytometry.Barriers to adherence with tuberculosis contact investigation in six provinces of Vietnam: a nested case-control study.Modeling the potential impact of host population survival on the evolution of M. tuberculosis latency.Tuberculosis prevention in South AfricaSystematic review and meta-analysis of the efficacy and safety of therapy with linezolid containing regimens in the treatment of multidrug-resistant and extensively drug-resistant tuberculosis.Modelling challenges in context: lessons from malaria, HIV, and tuberculosisTuberculosis Infection in the United States: Prevalence Estimates from the National Health and Nutrition Examination Survey, 2011-2012Control of Mycobacterial Infections in Mice Expressing Human Tumor Necrosis Factor (TNF) but Not Mouse TNF.Interleukin 27R regulates CD4+ T cell phenotype and impacts protective immunity during Mycobacterium tuberculosis infection.Prevalence of latent tuberculosis infection and predictive factors in an urban informal settlement in Johannesburg, South Africa: a cross-sectional study.Tuberculosis control in China: use of modelling to develop targets and policies.Helminth-induced arginase-1 exacerbates lung inflammation and disease severity in tuberculosisEffect of bacillus Calmette-Guérin vaccination on CD4+Foxp3+ T cells during acquired immune response to Mycobacterium tuberculosis infectionImproving Control of Tuberculosis in Low-Burden Countries: Insights from Mathematical Modeling.High-throughput identification and dendritic cell-based functional validation of MHC class I-restricted Mycobacterium tuberculosis epitopes.Three months of weekly rifapentine and isoniazid for treatment of Mycobacterium tuberculosis infection in HIV-coinfected personsDesign of Potential Bisubstrate Inhibitors against Mycobacterium tuberculosis (Mtb) 1-Deoxy-D-Xylulose 5-Phosphate Reductoisomerase (Dxr)-Evidence of a Novel Binding Mode.
P2860
Q21034169-F0022199-29DB-46F1-8833-A209D50CEA43Q26778619-3582562E-016A-44B5-B691-39B1CEB3E9F9Q26824057-62A85316-6ADA-40A3-9CBD-A67766B8DB19Q26865560-F3E149A8-E56F-44E3-83BE-D31A127076EBQ27681663-3AF59138-8212-434B-A83F-488D31F063E9Q27687284-1A22DDAD-B96A-4594-B555-CB6DCFE22658Q28067735-5A28AFD4-C59F-4DA5-9D80-334E81B15ED5Q28087385-66FEA1EA-9854-4B5F-B45B-06C66CE57AFCQ28386135-70019512-4A74-4874-B8DB-FF82D6D27DC2Q30391463-5E68EDB3-8628-4CB4-AB18-D3C7DEA82029Q31154267-10D52DA4-BA5E-455E-A8A7-0ADDB6F66DA2Q33675370-DA89ABEB-3A63-4A3C-8B71-22173544FF04Q33768889-058731C5-774D-4A90-AC2D-9BC2BE884F7CQ33798468-9981F776-EF56-4C4B-89CF-361BD821DDE1Q34424824-0680C62A-1EAE-46BB-A0A6-76468DE2ECFDQ34441930-A4D434A3-915C-4FF7-9594-0044AB2A5FEDQ34474397-6E626BDF-3D18-4086-A899-7C2348EAEC6FQ34714642-6214C85F-5745-40EA-83D0-5B703F61B8B5Q34994277-D65D2B53-CCB2-4957-AE19-57C05D80155AQ35039807-52A1A4F8-16E8-4B46-AD84-71E7EBBF6AB8Q35045088-C30BEB1C-5139-45C6-B23E-0BB17025C40FQ35054208-13601942-3979-41A2-A61E-1560FE2D662EQ35098182-07B91342-EA92-4F59-B1B8-059FE2A30773Q35117812-2346C5F3-9EC5-465D-8078-BAB07D244F0CQ35226186-40C27908-ED27-49F8-8F38-6D4A52F7036EQ35232078-98EEFB66-ADFA-46FD-8F8E-949A4BDE10A0Q35304473-8C1AA18A-86F1-4D88-B371-17DEE0D70E72Q35568367-6AA965B5-8644-4208-86AC-E57FFA7DB495Q35671092-57CC5D61-6AE4-4662-A4A3-7300D70CA61EQ35831899-33890266-7DE8-493F-BBAF-1AB1882AF12EQ35947483-AF640852-2101-410B-9D65-C319164B4B1CQ35992186-76CC50E8-6361-4D18-90B3-AAF97B479757Q36185964-121609FD-62D8-40D8-BC99-3B12F2A9ECCFQ36211825-A6F271E8-B840-4ABC-A41A-F834CD76DAF3Q36335912-FB6FA773-26D3-4F5E-8DE8-F0579F9C744FQ36676017-A8DDDB59-5679-4BBF-A7E9-FE83331B43C1Q36859680-1FFFA63C-5468-4267-8DF8-F8B3698B34CFQ36972511-BC2F567A-2305-4384-AFE8-4D08EF67A238Q36986755-96DF2109-B7B7-4B57-9BE6-526FC1FD61F4Q37063813-97748A3B-51EC-480D-9BD0-7B10FFB3D37F
P2860
description
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2013
@ast
im März 2013 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: 18 March 2013)
@en
wetenschappelijk artikel (gepubliceerd op 2013/03/18)
@nl
наукова стаття, опублікована в березні 2013
@uk
مقالة علمية (نشرت في 18-3-2013)
@ar
name
Prospects for Tuberculosis Elimination
@ast
Prospects for Tuberculosis Elimination
@en
type
label
Prospects for Tuberculosis Elimination
@ast
Prospects for Tuberculosis Elimination
@en
prefLabel
Prospects for Tuberculosis Elimination
@ast
Prospects for Tuberculosis Elimination
@en
P50
P3181
P1476
Prospects for Tuberculosis Elimination
@en
P2093
Katherine Floyd
P304
P3181
P356
10.1146/ANNUREV-PUBLHEALTH-031912-114431
P577
2013-03-18T00:00:00Z